Xiao‐Hui Gu

687 total citations
13 papers, 606 citations indexed

About

Xiao‐Hui Gu is a scholar working on Organic Chemistry, Molecular Biology and Cellular and Molecular Neuroscience. According to data from OpenAlex, Xiao‐Hui Gu has authored 13 papers receiving a total of 606 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Organic Chemistry, 4 papers in Molecular Biology and 3 papers in Cellular and Molecular Neuroscience. Recurrent topics in Xiao‐Hui Gu's work include Risk and Safety Analysis (3 papers), Cholesterol and Lipid Metabolism (2 papers) and Synthesis of Indole Derivatives (2 papers). Xiao‐Hui Gu is often cited by papers focused on Risk and Safety Analysis (3 papers), Cholesterol and Lipid Metabolism (2 papers) and Synthesis of Indole Derivatives (2 papers). Xiao‐Hui Gu collaborates with scholars based in China, United States and Sweden. Xiao‐Hui Gu's co-authors include Biao Jiang, John L. Neumeyer, Cai‐Guang Yang, Jean M. Bidlack, Ira G. Schulman, Richard Martin, Nancy K. Mello, Tielin Wang, Grace Yan and Raju Mohan and has published in prestigious journals such as Journal of Medicinal Chemistry, Tetrahedron Letters and Bioorganic & Medicinal Chemistry.

In The Last Decade

Xiao‐Hui Gu

12 papers receiving 589 citations

Peers

Xiao‐Hui Gu
Markus Boehringer Switzerland
Paul E. Wiedeman United States
Ligaya M. Simpkins United States
Barry Porter United Kingdom
Lan Shen United States
Feroze Ujjainwalla United States
Simon J. Coutts United States
Markus Boehringer Switzerland
Xiao‐Hui Gu
Citations per year, relative to Xiao‐Hui Gu Xiao‐Hui Gu (= 1×) peers Markus Boehringer

Countries citing papers authored by Xiao‐Hui Gu

Since Specialization
Citations

This map shows the geographic impact of Xiao‐Hui Gu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xiao‐Hui Gu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xiao‐Hui Gu more than expected).

Fields of papers citing papers by Xiao‐Hui Gu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Xiao‐Hui Gu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xiao‐Hui Gu. The network helps show where Xiao‐Hui Gu may publish in the future.

Co-authorship network of co-authors of Xiao‐Hui Gu

This figure shows the co-authorship network connecting the top 25 collaborators of Xiao‐Hui Gu. A scholar is included among the top collaborators of Xiao‐Hui Gu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Xiao‐Hui Gu. Xiao‐Hui Gu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

13 of 13 papers shown
1.
Kick, Ellen K., Richard Martin, Yinong Xie, et al.. (2014). Liver X Receptor (LXR) partial agonists: Biaryl pyrazoles and imidazoles displaying a preference for LXRβ. Bioorganic & Medicinal Chemistry Letters. 25(2). 372–377. 33 indexed citations
2.
Wang, Jin, et al.. (2011). Design and implementation of a database for nuclear power plant risk monitor. 31(3). 252–257.
3.
Fang, Wang, Jin Wang, Xiao‐Hui Gu, et al.. (2011). Application of calculation engine of RiskA to nuclear power plant's probabilistic safety assessment. Chinese Journal of Nuclear Science and Engineering. 31(1). 75–79. 2 indexed citations
4.
Li, Yazhou, et al.. (2010). Development and Application of a Risk Monitor for Nuclear Power Plant. 697–701. 2 indexed citations
5.
Martin, Richard, Tielin Wang, Paige E. Mahaney, et al.. (2009). Discovery of XL335 (WAY-362450), a Highly Potent, Selective, and Orally Active Agonist of the Farnesoid X Receptor (FXR). Journal of Medicinal Chemistry. 52(4). 904–907. 141 indexed citations
6.
Neumeyer, John L., Ao Zhang, Wennan Xiong, et al.. (2003). Design and Synthesis of Novel Dimeric Morphinan Ligands for κ and μ Opioid Receptors. Journal of Medicinal Chemistry. 46(24). 5162–5170. 71 indexed citations
8.
Neumeyer, John L., Xiao‐Hui Gu, Nicholas J. DeNunzio, et al.. (2001). Mixed κ agonists and μ agonists/Antagonists as potential pharmacotherapeutics for cocaine abuse: synthesis and opioid receptor binding affinity of N-substituted derivatives of morphinan. Bioorganic & Medicinal Chemistry Letters. 11(20). 2735–2740. 23 indexed citations
9.
Jiang, Biao, Cai‐Guang Yang, & Xiao‐Hui Gu. (2001). A highly stereoselective synthesis of indolyl N-substituted glycines. Tetrahedron Letters. 42(13). 2545–2547. 40 indexed citations
10.
Jiang, Biao & Xiao‐Hui Gu. (2000). Syntheses and cytotoxicity evaluation of bis(indolyl)thiazole, bis(indolyl)pyrazinone and bis(indolyl)pyrazine: analogues of cytotoxic marine bis(indole) alkaloid. Bioorganic & Medicinal Chemistry. 8(2). 363–371. 107 indexed citations
11.
Jiang, Biao & Xiao‐Hui Gu. (2000). Syntheses of Bis(3’-indolyl)-2(1H)-pyrazinones. Heterocycles. 53(7). 1559–1559. 24 indexed citations
12.
Gu, Xiao‐Hui, et al.. (1999). Syntheses and biological activities of bis(3-indolyl)thiazoles, analogues of marine bis(indole)alkaloid nortopsentins. Bioorganic & Medicinal Chemistry Letters. 9(4). 569–572. 134 indexed citations
13.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026